InvestorsHub Logo
Followers 49
Posts 9775
Boards Moderated 1
Alias Born 01/31/2008

Re: Reyeton post# 105498

Thursday, 05/18/2017 12:30:36 PM

Thursday, May 18, 2017 12:30:36 PM

Post# of 458279
Agree there has been too much overemphasis on Biogen. I think more logical partners are Easai for Asia and Pfizer for US/ROW. they are makers of Aricept, so they have the most to lose from 273, and they know the customers and have the distribution in place. Plus they are big and can afford to pay a royal price to protect their franchise.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News